Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications
Sign Up to like & getrecommendations! Published in 2017 at "OncoImmunology"
DOI: 10.1080/2162402x.2017.1371896
Abstract: ABSTRACT The goal of cancer immunotherapy is to establish new or boost pre-existing anticancer immune responses that eradicate malignant cells while generating immunological memory to prevent disease relapse. Over the past few years, immunomodulatory monoclonal… read more here.
Keywords: immunostimulatory monoclonal; monoclonal antibodies; trial watch; watch immunostimulatory ... See more keywords